We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Diurnal Group Plc | LSE:DNL | London | Ordinary Share | GB00BDB6Q760 | ORD GBP0.05 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 27.30 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
26/3/2021 07:03 | Bloody hell its friyay already. see you all Monday! | aimmafia | |
26/3/2021 07:02 | Make that Monday... | affc21 | |
26/3/2021 07:00 | See you all tomorrow | aimmafia | |
26/3/2021 06:50 | Morning all. T minus 11 minutes for a possible rns. Awaiting patiently "again" if it doesnt arrive... see you all Monday lol | aimmafia | |
26/3/2021 06:36 | I suspect someone misspelling the word ‘herd’ is not someone you should really be taking investment advice from. | sapper2476 | |
25/3/2021 23:03 | Was that English?? | small crow | |
25/3/2021 22:36 | Heard arrived, all be it pink | l0ngterm | |
25/3/2021 21:26 | hxxps://pink.pharmai | weatherman | |
25/3/2021 18:11 | Remember they have a potential pipeline of $9.5bn which includes Alkindi, Chronocort, Ditest. Green light for Chronocort will send it well high imho. Exciting times ahead. | frrinvest | |
25/3/2021 18:07 | About 180k actually :) | talk2dubya | |
25/3/2021 18:02 | I think you could see the RNS tomorrow. I am quietly confident. | frrinvest | |
25/3/2021 17:59 | Gap up tomorrow then? | irpy | |
25/3/2021 17:57 | Looks like it | shrewdmole | |
25/3/2021 17:52 | Back to business, was that 200k in buys after hours and over the closing price? | l0ngterm | |
25/3/2021 17:48 | They have already answered remaining questions after re-submission. These questions were answered in two sets: In set-1 were 120, all answered (Nov. 2020). In set -2, only a few more, again all answered (Feb. 2021). Nothing else left. I think chances of approval are high but you can never tell with these regulatory bodies. The CEO of DNL was quite impressive in his recent presentation he gave where he stipulated all this. Fingers crossed! | frrinvest | |
25/3/2021 17:35 | And here: Following a Scientific Advice meeting with EMA representatives to discuss the Phase III Chronocort results in CAH patients, the EMA has confirmed that the MAA for Chronocort can be submitted with no further trials needed; DNL expects to submit this in 4Q'19.https://www.ha | l0ngterm | |
25/3/2021 17:33 | Why more data? It was reported that ema did not require any more data, after the discussions with the ema. Then it was proceed and submit https://markets.ft.c | l0ngterm | |
25/3/2021 17:30 | The previous RNS says they are fully expecting approval - i would be extremely surprised if we don't get it. However this is serious stuff so anything can happen. DNL would have have spent a serious amount of time getting this approved and over the line and I doubt they will let this opportunity slip through their hands. | aimmafia | |
25/3/2021 17:29 | Was that 200k shares bought after hours? | l0ngterm | |
25/3/2021 17:21 | Well what are the downside scenarios for the EMA decision, and the consequence for each?Seems to me unlikely that there will be an outright rejection.Worst case scenario is they say more data needed.? If so how much time/money is that likely to take? | cyberbub | |
25/3/2021 16:55 | More likely to be monday but who knows | shrewdmole | |
25/3/2021 16:39 | More selling down than I had anticipated seeing after the nice early rise today. Lets hope for good news tomorrow. GLA! | lovewinshatelosses | |
25/3/2021 15:51 | Have the bed sheets been changed now? | irpy |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions